Close

Clinical Trials

Biogen Idec Receives Positive Opinion from the CHMP and...

Biogen Idec announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval...

Boehringer Ingelheim’s lead hepatitis C compound moves into phase...

Boehringer Ingelheim announced the study outline for the pivotal Phase III clinical trials designed to evaluate BI 201335, its investigational once-daily oral protease inhibitor, in...

Addex Initiates Phase IIa Clinical Trial of Dipraglurant-IR in...

  Allosteric modulation company Addex Pharmaceuticals (SIX:ADXN) announced today the initiation of a Phase IIa clinical trial to evaluate dipraglurant in patients with Parkinson’s disease...

Adocia reports positive phase I clinical results on HinsBet(R),...

Adocia, a privately-held biotechnology company specialized in regenerative medicine and in the treatment of chronic diseases, announced today positive results from its phase I clinical...

Infinity Initiates Phase 2 Trial of IPI-926 in Patients...

Infinity Pharmaceuticals, Inc. announced the initiation of a randomized, double-blind Phase 2 clinical trial to evaluate the safety and efficacy of IPI-926 compared to placebo...

NovaBay Pharmaceuticals Initiates Phase 2 Clinical Trial for the...

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing its first-in-class, anti-infective Aganocide compounds for the local non-systemic treatment and prevention of antibiotic-resistant infections, today...

GlaxoSmithKline and Human Genome Sciences announce publication of BLISS-52...

GlaxoSmithKline (GSK)  and Human Genome Sciences, Inc. announced publication of the BLISS-52 study of Benlysta® (belimumab) in autoantibody-positive patients with active systemic lupus erythematosus (SLE)...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read